ID   SIAT6_RAT               Reviewed;         374 AA.
AC   Q02734;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   24-JUL-2024, entry version 140.
DE   RecName: Full=CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase;
DE            EC=2.4.3.6 {ECO:0000250|UniProtKB:P97325};
DE   AltName: Full=Beta-galactoside alpha-2,3-sialyltransferase 3;
DE            Short=Alpha 2,3-ST 3;
DE   AltName: Full=Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase;
DE   AltName: Full=N-acetyllactosaminide alpha-2,3-sialyltransferase;
DE   AltName: Full=ST3Gal III;
DE            Short=ST3GalIII;
DE   AltName: Full=ST3N;
DE   AltName: Full=Sialyltransferase 6;
DE   Contains:
DE     RecName: Full=CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase soluble form;
GN   Name=St3gal3; Synonyms=Siat6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=1400416; DOI=10.1016/s0021-9258(19)36790-0;
RA   Wen D.X., Livingston B.D., Medzihradszky K.F., Kelm S., Burlingame A.L.,
RA   Paulson J.C.;
RT   "Primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase
RT   determined by mass spectrometry sequence analysis and molecular cloning.
RT   Evidence for a protein motif in the sialyltransferase gene family.";
RL   J. Biol. Chem. 267:21011-21019(1992).
CC   -!- FUNCTION: Catalyzes the formation of the NeuAc-alpha-2,3-Gal-beta-1,4-
CC       GlcNAc-, NeuAc-alpha-2,3-Gal-beta-1,3-GlcNAc- and NeuAc-alpha-2,3-Gal-
CC       beta-1,3-GalNAc- sequences found in terminal carbohydrate groups of
CC       glycoproteins and glycolipids. The highest activity is toward Gal-beta-
CC       1,3-GlcNAc and the lowest toward Gal-beta-1,3-GalNAc.
CC       {ECO:0000250|UniProtKB:P97325}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl
CC         derivative + CMP-N-acetyl-beta-neuraminate = an N-acetyl-alpha-
CC         neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-
CC         glucosaminyl derivative + CMP + H(+); Xref=Rhea:RHEA:52316,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57812, ChEBI:CHEBI:60377,
CC         ChEBI:CHEBI:133507, ChEBI:CHEBI:136545; EC=2.4.3.6;
CC         Evidence={ECO:0000250|UniProtKB:P97325};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-
CC       pass type II membrane protein. Secreted. Note=Membrane-bound form in
CC       trans cisternae of Golgi. Secreted into the body fluid.
CC   -!- TISSUE SPECIFICITY: Found in all tissues tested. High expression found
CC       in brain, liver, kidney, colon, heart and lung.
CC   -!- PTM: The soluble form derives from the membrane form by proteolytic
CC       processing.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 29 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M97754; AAA42146.1; -; mRNA.
DR   PIR; A45074; A45074.
DR   RefSeq; NP_113885.1; NM_031697.1.
DR   AlphaFoldDB; Q02734; -.
DR   SMR; Q02734; -.
DR   STRING; 10116.ENSRNOP00000053685; -.
DR   BindingDB; Q02734; -.
DR   ChEMBL; CHEMBL3211; -.
DR   CAZy; GT29; Glycosyltransferase Family 29.
DR   GlyCosmos; Q02734; 2 sites, No reported glycans.
DR   GlyGen; Q02734; 2 sites.
DR   PhosphoSitePlus; Q02734; -.
DR   PaxDb; 10116-ENSRNOP00000053685; -.
DR   GeneID; 64445; -.
DR   KEGG; rno:64445; -.
DR   UCSC; RGD:68414; rat.
DR   AGR; RGD:68414; -.
DR   CTD; 6487; -.
DR   RGD; 68414; St3gal3.
DR   eggNOG; KOG2692; Eukaryota.
DR   InParanoid; Q02734; -.
DR   OrthoDB; 5404317at2759; -.
DR   PhylomeDB; Q02734; -.
DR   BRENDA; 2.4.99.6; 5301.
DR   Reactome; R-RNO-2022854; Keratan sulfate biosynthesis.
DR   Reactome; R-RNO-4085001; Sialic acid metabolism.
DR   Reactome; R-RNO-9037629; Lewis blood group biosynthesis.
DR   Reactome; R-RNO-977068; Termination of O-glycan biosynthesis.
DR   Reactome; R-RNO-9840309; Glycosphingolipid biosynthesis.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q02734; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003836; F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; ISO:RGD.
DR   GO; GO:0008118; F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; TAS:RGD.
DR   GO; GO:0008373; F:sialyltransferase activity; IBA:GO_Central.
DR   GO; GO:0010706; P:ganglioside biosynthetic process via lactosylceramide; ISO:RGD.
DR   GO; GO:0006486; P:protein glycosylation; ISO:RGD.
DR   Gene3D; 3.90.1480.20; Glycosyl transferase family 29; 1.
DR   InterPro; IPR001675; Glyco_trans_29.
DR   InterPro; IPR051142; Glycosyltransferase_29.
DR   InterPro; IPR038578; GT29-like_sf.
DR   InterPro; IPR012163; Sialyl_trans.
DR   PANTHER; PTHR13713:SF37; CMP-N-ACETYLNEURAMINATE-BETA-1,4-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; 1.
DR   PANTHER; PTHR13713; SIALYLTRANSFERASE; 1.
DR   Pfam; PF00777; Glyco_transf_29; 1.
DR   PIRSF; PIRSF005557; Sialyl_trans; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Membrane; Reference proteome;
KW   Secreted; Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..374
FT                   /note="CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-
FT                   2,3-sialyltransferase"
FT                   /id="PRO_0000012143"
FT   CHAIN           48..374
FT                   /note="CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-
FT                   2,3-sialyltransferase soluble form"
FT                   /id="PRO_0000012144"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..374
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   SITE            46..47
FT                   /note="Cleavage; partial"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        170
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        159..313
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   374 AA;  42082 MW;  16BAD1458963024C CRC64;
     MGLLVFVRNL LLALCLFLVL GFLYYSAWKL HLLQWEDSNS LILSLDSAGQ TLGTEYDRLG
     FLLKLDSKLP AELATKYANF SEGACKPGYA SAMMTAIFPR FSKPAPMFLD DSFRKWARIR
     EFVPPFGIKG QDNLIKAILS VTKEYRLTPA LDSLHCRRCI IVGNGGVLAN KSLGSRIDDY
     DIVIRLNSAP VKGFEKDVGS KTTLRITYPE GAMQRPEQYE RDSLFVLAGF KWQDFKWLKY
     IVYKERVSAS DGFWKSVATR VPKEPPEIRI LNPYFIQEAA FTLIGLPFNN GLMGRGNIPT
     LGSVAVTMAL DGCDEVAVAG FGYDMNTPNA PLHYYETVRM AAIKESWTHN IQREKEFLRK
     LVKARVITDL SSGI
//
